Import, Export, and Customs for Clinical Supplies: Avoiding the Delays No One Plans For

Every element of a global trial's supply chain gets a plan — the forecast, the packaging strategy, the depot network, the resupply logic. And then the drug reaches a border, and all of that careful planning waits in a customs queue behind a paperwork error nobody budgeted time for.

Cross-border movement is the least glamorous and most under-planned part of clinical supply, and it punishes that neglect reliably. A shipment held at customs isn't just late — it's often sitting in uncontrolled conditions, burning shelf life and risking a temperature excursion, while a site runs low and a patient's visit approaches. Here's how to plan the part of the supply chain that lives between countries.

Why customs is the weak point

Customs and in-transit handovers are widely regarded as the most vulnerable points in the entire clinical supply chain, and the reasons are structural.

At a border, your shipment leaves systems you control and enters a process you don't. Clearance depends on documentation being exactly right, on local regulations you may not specialize in, on a broker you may not have chosen, and on officials applying rules with local discretion. Any one of those going wrong stops the shipment — and unlike a depot delay, you often can't expedite your way out of it.

Layered on top is the physical risk: product held at a border is frequently outside validated storage conditions. For temperature-sensitive biologics, a multi-day customs hold can do what the whole rest of the cold chain was designed to prevent.

The documentation that actually determines clearance

Most customs delays trace back to documentation — either missing, inconsistent, or wrong for that specific country.

• Import licenses and permits. Many countries require a specific import license or permit for investigational product, and obtaining one can take weeks or months. This is a lead-time item, not a shipping-day item.
• Accurate commercial and proforma documentation. Values, descriptions, quantities, and product classifications must be consistent across every document. A mismatch between the invoice and the packing list is enough to trigger a hold.
• Regulatory and IMP documentation. Proof of the trial's regulatory approval and the product's status often has to accompany the shipment.
• Correct product classification. The tariff and regulatory classification of the product drives how it's treated at the border. Getting it wrong causes delays and can create unexpected duty exposure.
• Import/export authorizations for controlled or special-handling products. Some products carry additional layers of control that must be secured in advance.

The pattern across all of these: the work that prevents a customs delay happens weeks before the shipment moves, not on the day it ships.

Country variation is the rule, not the exception

There is no universal customs process. Requirements, timelines, documentation, and even whether a given comparator source is acceptable vary country by country — and they change. A process that cleared smoothly last quarter can shift with a regulatory or trade update.

This is why "we've shipped to that region before" is a dangerous source of confidence. Each country in your trial needs its own mapped import pathway, confirmed current, with realistic lead times built into the plan.

Choosing and managing customs brokers and partners

At the border, your broker is effectively acting on your behalf, and their competence largely determines your outcome. The best-run trials treat broker and logistics partner selection as seriously as depot selection.

• Verify genuine IMP and clinical experience in the specific countries you're shipping to — not just general freight capability.
• Confirm temperature-controlled competence, including what happens to your shipment if it's held.
• Establish clear escalation paths so a hold reaches a decision-maker fast, not a shared inbox.
• Agree documentation responsibilities explicitly, so there's no ambiguity about who prepares and checks what.

Planning for the delays you can't eliminate

Some border friction is unavoidable. The goal is to make it non-disruptive.

1. Build realistic customs lead times into the forecast — including worst-case, not just typical, clearance times for each country.
2. Secure permits and licenses early, treating them as long-lead items in study start-up.
3. Position buffer stock in-region so a single delayed shipment doesn't immediately threaten a site. In-country or in-region depots exist partly to absorb border risk.
4. Protect the cold chain through customs, using packaging validated for the worst-case hold duration and real-time monitoring so you know immediately if a held shipment is at risk.
5. Plan the return and destruction pathway too. Re-exporting or destroying unused product at the end of a trial has its own customs requirements, and it's routinely forgotten until it's urgent.
6. Keep documentation inspection-ready. Import/export records are part of your traceability chain and part of what an inspection can examine.